Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NIR-ICG Imaging of Lymphatic Transport in Rheumatoid Arthritis
NCT05197530Phase 1Recruiting
- Sponsor
- University of Rochester
- Start
- Dec 2021
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of indocyanine green in rheumatoid arthritis (RA) (2 arms), sponsored by University of Rochester. Primary endpoint: ICG Clearance at 1 week. Started Dec 2021; status: recruiting.
02
Drugs
indocyanine green
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT05197530.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05197530.